ALT is the blood test most likely to be quietly wrong about you in the reassuring direction. Many U.S. labs print an upper limit somewhere between the mid-40s and the 60s — and the American College of Gastroenterology’s evidence-based ceiling for a genuinely healthy liver is 33 U/L for men and 25 for women. That gap isn’t a technicality. It’s where early metabolic liver trouble lives, wearing a green checkmark.
What the test actually measures
Alanine aminotransferase (ALT, old name SGPT) is an enzyme that lives mostly inside liver cells. When liver cells are stressed or injured, ALT leaks into the bloodstream — so the blood level is a running readout of how irritated your liver is right now. A small amount of ALT also lives in muscle, which is why one hard week in the gym can nudge it (more on that below).
ALT rarely travels alone: it’s drawn as part of a comprehensive metabolic panel or hepatic panel, usually next to AST, its blunter sibling. The two are read together — the ratio carries information the individual numbers don’t.
Why the lab’s range is the most contested number on the page
Reference ranges are built from “apparently healthy” populations. The problem, demonstrated back in 2002: those populations were salted with people who had undiagnosed fatty liver, so the “normal” ceiling absorbed their elevated values. When researchers rebuilt the range using only blood donors with healthy weight and negative hepatitis testing, the true upper limits fell to roughly 30 U/L for men and 19 for women. The ACG’s 2017 clinical guideline turned that into practice: use 33 (men) / 25 (women) as the upper limit of a healthy ALT, and evaluate levels above it.
That matters because the condition doing most of the inflating — now called MASLD (metabolic dysfunction–associated steatotic liver disease, the condition formerly known as fatty liver / NAFLD) — affects roughly 3 in 10 adults worldwide and is the most common reason an American’s ALT runs high. Most people who have it don’t know. A lab range widened by an epidemic is not a health target.
| ALT (U/L) | The honest read |
|---|---|
| Very low (single digits) | Usually meaningless. Vitamin B6 deficiency can suppress it; in older adults, very low ALT loosely tracks with muscle loss in observational data — a curiosity to mention to a clinician, not a finding |
| Up to 25 (women) / 33 (men) | The healthy zone by the ACG’s evidence-based limits — where a well liver actually sits |
| Above 33/25 but under the lab’s printed limit | The gap. Flagged “normal” by the printout, above the guideline ceiling. The most common resident here is early metabolic liver stress — worth a repeat draw and a look at weight, alcohol, medications, and the metabolic markers, not a panic |
| Above the lab’s limit, up to a few times over | Confirmed on repeat, this is a real workup: MASLD, alcohol, medications and supplements, viral hepatitis, iron overload are the usual suspects — a clinician’s differential, not a blog’s |
| Many times the upper limit | Acute liver injury territory. Not a trend-watching situation — involve a clinician promptly |
One more honesty note, in the other direction: a normal ALT does not clear your liver. The full spectrum of MASLD — including its aggressive form — has been documented in people with normal ALT values. That’s precisely why this number is read alongside fasting insulin, HbA1c, triglycerides, and waist-adjacent reality, not as a solo verdict.
No symptoms is the usual presentation
An ALT of 55 feels like nothing. The liver famously doesn’t complain until late — early metabolic liver disease produces no reliable sensation at all, which is the entire argument for measuring rather than waiting. By the time liver trouble announces itself (jaundice, fluid retention, the dramatic chapter), the trend line has usually been drifting for years. ALT is one of the few places that drift shows up early, cheaply, and reversibly.
The AST:ALT ratio, in one paragraph
In metabolic liver stress, ALT typically runs higher than AST. When AST runs at least twice ALT, the pattern historically points toward alcohol-related injury. And when both are up after a brutal training week, the culprit may be muscle, not liver — AST and creatine kinase rise more than ALT after strenuous exercise, and the effect can linger most of a week. Practical corollary: don’t schedule your draw two days after the hardest workout of your year, and don’t let one post-marathon panel write a story a repeat draw would delete.
What moves it
- Weight, in both directions. The single most powerful lever. In trial data, losing ~10% of body weight resolved the aggressive form of fatty liver in the large majority of patients; even ~5% measurably reduces liver fat — and ALT falls with it.
- Alcohol — dose-dependent, and it stacks with metabolic risk rather than politely taking turns.
- Medications — statins, acetaminophen at sustained high doses, some antibiotics and antifungals can raise ALT; that’s a review-with-your-prescriber conversation, never a stop-on-your-own decision.
- Botanical supplements — a rising, under-appreciated cause of documented liver injury in the U.S. registry data: turmeric/curcumin, ashwagandha, and green-tea extract lead the recent lists. “Natural” and “hepatically boring” are different claims. If your ALT is up and your cabinet is full, bring the bottles to the appointment.
- The metabolic cluster — insulin resistance is the engine under most high-normal ALTs; the liver is where the metabolic story becomes visible tissue. Coffee, for what it’s worth, keeps showing protective associations in the liver literature — a pleasant footnote, not a treatment.
- Iron overload — hereditary hemochromatosis quietly raises ALT for years; it’s the reason an elevated ALT is read next to ferritin, and one of the better arguments for panels over single tests.
The loop: measure → change one real thing → retest in about 8–12 weeks. ALT responds to weight and alcohol changes inside a couple of months, which makes it one of the most satisfying markers to actually watch move. (Stated plainly: the retest is the product.)
ALT and the rest of the picture
- Fasting insulin and HbA1c — the engine gauges; a high-normal ALT with rising insulin is a coherent story, not two coincidences.
- Ferritin — the iron-overload check that turns “mildly elevated ALT” from a shrug into a findable diagnosis.
- AST, GGT, bilirubin, platelets — the supporting cast a physician reads around an ALT before deciding whether anything needs a next step.
Browse the full biomarker library to see everything the panel covers.
How to get your ALT tested
Three realistic routes:
- Ask at your physical. ALT is inside the standard comprehensive metabolic panel (CMP) — you’ve probably had it drawn a dozen times. The catch isn’t access; it’s the interpretation gap this page is about: a 48 reads “normal” on the printout and above the guideline ceiling in the literature, and busy primary care rarely has the appointment-minutes to litigate that difference.
- Order it a la carte. ALT is almost never sold alone — DTC storefronts sell the CMP for roughly $23–49, and a Quest hepatic panel runs about $31 through resellers (verified August 2026; route-by-route detail in our full-body blood test cost guide). One trap worth knowing: a hepatic panel shares six of its seven analytes with a CMP — buying both is paying twice for the same tube.
- Measure it inside a full panel a physician actually reads. Terve Health is a whole-body panel — drawn at any of 2,000+ Quest locations, ordered by a licensed clinician, and returned as a written plain-language review that reads your ALT against your insulin, HbA1c, ferritin, and lipids, which is the only way this particular number means anything. You don’t choose a panel — a physician orders the right one for you. And if a result needs real follow-up, the medical practice behind your panel can actually see you.
Frequently asked questions
What is a good ALT level? By the American College of Gastroenterology’s evidence-based limits: up to 33 U/L for men and 25 U/L for women. Many U.S. labs print higher ceilings (mid-40s to 60s) because their reference populations included people with undiagnosed fatty liver. Between the guideline number and the lab number is the zone worth a second look — not alarm, a look.
Why is my ALT slightly elevated? Confirmed on a repeat draw, the common answers in rough order: metabolic liver stress (MASLD — the most common cause in the U.S.), alcohol, medications or botanical supplements, a recent bout of very hard exercise, and less often viral hepatitis or iron overload. The pattern around it — AST ratio, ferritin, metabolic markers — is how a clinician tells those apart.
Can my ALT be normal and my liver still not be fine? Yes. The full spectrum of metabolic liver disease has been documented at normal ALT values. A normal ALT is good news, not a clearance certificate — which is why it’s read with the metabolic panel around it rather than alone.
What does the AST/ALT ratio mean? ALT higher than AST is the typical metabolic-stress pattern. AST at least twice ALT historically points toward alcohol-related injury. Both elevated right after strenuous exercise may be muscle, not liver — retest after a normal week before concluding anything.
Do I need to fast for an ALT test? Not for ALT itself. It’s usually drawn inside a CMP, which is often done fasting for the glucose — so in practice you’ll likely fast anyway. Skipping the gym for a couple of days before the draw does more for ALT accuracy than skipping breakfast.
How do I lower my ALT? The evidence-backed levers are unglamorous: weight loss if there’s weight to lose (~5% helps, ~10% is transformative in trial data), less alcohol, and a medication-and-supplement review with your prescriber. Then retest in 8–12 weeks — ALT is one of the fastest-responding numbers on the panel, which makes it a genuinely motivating one to track.
Sources
- Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017. (ULN 33 M / 25 F; evaluation algorithm.)
- Prati D, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002. (Rebuilt ranges ~30/19; reference-population contamination.)
- Rinella ME, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023. (MASLD naming.)
- Younossi ZM, et al. The global epidemiology of nonalcoholic fatty liver disease. Hepatology. 2023. (~30% adult prevalence.)
- Mofrad P, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003. (Normal-ALT MASLD.)
- Vilar-Gomez E, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015. (5%/10% weight-loss outcomes.)
- Navarro VJ, et al. Liver injury from herbal and dietary supplements (U.S. DILIN). Hepatology. 2017 (+ DILIN registry updates on turmeric/ashwagandha/green-tea extract). (Botanical liver injury.)
- Pettersson J, et al. Muscular exercise can cause highly pathological liver function tests in healthy men. Br J Clin Pharmacol. 2008. (Post-exercise AST/ALT elevation and duration.)
Terve Health measures and helps you understand your biomarkers; it does not diagnose, treat, or prevent disease. Laboratory testing performed by Quest Diagnostics®; testing is ordered and results are reviewed by licensed clinicians at an independent medical practice. Always discuss abnormal results, medications, and supplements with a licensed clinician.